Plunkett Research Online: G1 Therapeutics

G1 THERAPEUTICS (GTHX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer, such as cell lung cancer and breast c.....


G1 THERAPEUTICS

Ticker: GTHX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 919 213-9835
Fax: 919 741-5830
Address: 79 T.W. Alexander Drive
Research Triangle Park, NC 27709 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

John BaileyCEO/Director/President
John UmsteadCFO
See More
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer, such as cell lung cancer and breast c.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture